deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00453154

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Combination Chemotherapy With or Without Maintenance Sunitinib Malate (NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/Randomized Phase II Study

Sponsor: National Cancer Institute (NCI)

Updated 23 times since 2017 Last updated: Mar 31, 2023 Started: Mar 15, 2007 Primary completion: Jun 30, 2013 Completion: Aug 20, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Extensive Stage Lung Small Cell Carcinoma and Recurrent Lung Small Cell Carcinoma, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 23 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Oct 2019 · 3 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~May 2023 · 28 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

23 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  4. May 2023 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2021 — May 2023 [monthly]

    Completed PHASE1_PHASE2

Show 18 earlier versions
  1. May 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not RecruitingCompleted

  2. Apr 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Mar 2020 — Apr 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Feb 2020 — Mar 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Jan 2020 — Feb 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  6. Dec 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  7. Nov 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  8. Oct 2019 — Nov 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  9. Jul 2019 — Oct 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  10. May 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  11. Mar 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  12. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  13. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  14. Nov 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  15. Sep 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  16. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  17. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  18. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .